Search

Your search keyword '"Neuraminidase antagonists & inhibitors"' showing total 2,253 results

Search Constraints

Start Over You searched for: Descriptor "Neuraminidase antagonists & inhibitors" Remove constraint Descriptor: "Neuraminidase antagonists & inhibitors"
2,253 results on '"Neuraminidase antagonists & inhibitors"'

Search Results

1. Targeted recruitment of immune effector cells for rapid eradication of influenza virus infections.

2. Inhibition of Lysosomal Cathepsin A and Neuraminidase 1 Interaction by Anti-Obesity Cyclic Peptide.

3. Chemoenzymatic synthesis of sialyl-α2,3-lactoside-functionalized BSA conjugate inhibits influenza infection.

4. Dual neutralization of influenza virus hemagglutinin and neuraminidase by a bispecific antibody leads to improved antiviral activity.

5. Discovery of new quinoline derivatives bearing 1-aryl-1,2,3-triazole motif as influenza H1N1 virus neuraminidase inhibitors.

6. Fighting the flu: a brief review on anti-influenza agents.

7. The Amaryllidaceae alkaloid, montanine, is a potential inhibitor of the Trypanosoma cruzi trans-sialidase enzyme.

8. Novel sialidase inhibitors suppress mumps virus replication and infection.

9. The Synergistic Effect of Baloxavir and Neuraminidase Inhibitors against Influenza Viruses In Vitro.

10. Genotypic and phenotypic susceptibility of emerging avian influenza A viruses to neuraminidase and cap-dependent endonuclease inhibitors.

11. Bioisosteres at C9 of 2-Deoxy-2,3-didehydro- N -acetyl Neuraminic Acid Identify Selective Inhibitors of NEU3.

12. A Zanamivir-protein conjugate mimicking mucin for trapping influenza virion particles and inhibiting neuraminidase activity.

13. Computational screening and MM/GBSA-based MD simulation studies reveal the high binding potential of FDA-approved drugs against Cutibacterium acnes sialidase.

14. Citrus-derived flavanones as neuraminidase inhibitors: In vitro and in silico study.

15. Indole-core inhibitors of influenza a neuraminidase: iterative medicinal chemistry and molecular modeling.

16. Bisabolane-type sesquiterpenoids and bacillibactin from the marine-derived fungus Aspergillus sydowii SCSIO 41041 and their enzyme inhibiting activity.

17. Discovery of novel potent drugs for influenza by inhibiting the vital function of neuraminidase via fragment-based drug design (FBDD) and molecular dynamics simulation strategies.

18. Bacterial neuraminidase inhibitory chalcones from flowers of Coreopsis lanceolata, their kinetic characterization and antibiofilm effect.

19. Selaginella tamariscina Ethanol Extract Attenuates Influenza A Virus Infection by Inhibiting Hemagglutinin and Neuraminidase.

20. Glycopolymer with Sulfated Fucose and 6'-Sialyllactose as a Dual-Targeted Inhibitor on Resistant Influenza A Virus Strains.

21. Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023.

22. Global emergence of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses with I223V and S247N mutations: implications for antiviral resistance monitoring.

23. Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023-February 2024.

24. Pharmacoeconomic study of anti-influenza virus drugs in Japan based on a network meta-analysis.

25. Pharmacophore-based virtual screening, molecular docking and molecular dynamics studies for the discovery of novel neuraminidase inhibitors.

26. Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022-2023.

27. Therapeutic potential activity of quercetin complexes against Streptococcus pneumoniae.

28. Design, synthesis and neuraminidase inhibitory activity of 4-methyl-5-(3-phenylacryloyl) thiazoles.

29. Design, synthesis, docking, and antiviral evaluation of some novel pyrimidinone-based α-aminophosphonates as potent H1N1 and HCoV-229E inhibitors.

30. Discovery andsynthesis of novel benzoylhydrazone neuraminidase inhibitors.

31. Neuraminidase inhibition promotes the collective migration of neurons and recovery of brain function.

32. Treating influenza with neuraminidase inhibitors: an update of the literature.

33. Inhibition of neuraminidase-1 sialidase activity by interfering peptides impairs insulin receptor activity in vitro and glucose homeostasis in vivo.

34. Development and characterization of an antibody that recognizes influenza virus N1 neuraminidases.

35. Visualizing intracellular sialidase activity of influenza A virus neuraminidase using a fluorescence imaging probe.

36. Design, synthesis and biological evaluation of sulfamethazine derivatives as potent neuraminidase inhibitors.

37. Neuraminidase-dependent entry of influenza A virus is determined by hemagglutinin receptor-binding specificity.

38. A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.

39. A practical and rapid screening method for influenza virus neuraminidase inhibitors based on fluorescence detection.

40. Influenza antivirals and their role in pandemic preparedness.

41. Study on the Interaction between Silibinin and Neuraminidase.

42. Urolithin M5 from the Leaves of Canarium album (Lour.) DC. Inhibits Influenza Virus by Targeting Neuraminidase.

43. Frequency and distribution of H1N1 influenza A viruses with oseltamivir-resistant mutations worldwide before and after the 2009 pandemic.

44. Neuraminidase inhibitor treatment is associated with decreased mortality in COVID-19 patients: a retrospective analysis.

45. Design, synthesis and biological evaluation of 1,3,4-triazole-3-acetamide derivatives as potent neuraminidase inhibitors.

46. Intermolecular Mechanism and Dynamic Investigation of Avian Influenza H7N9 Virus' Susceptibility to E119V-Substituted Peramivir-Neuraminidase Complex.

47. Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole derivatives as potent neuraminidase inhibitors.

48. Human Neuraminidases: Structures and Stereoselective Inhibitors.

49. Neuraminidase Inhibitor of Garcinia atroviridis L. Fruits and Leaves Using Partial Purification and Molecular Characterization.

50. The effects of mutation on the drug binding affinity of Neuraminidase: case study of Capsaicin using steered molecular dynamics simulation.

Catalog

Books, media, physical & digital resources